Exact Mass: 511.1592878
Exact Mass Matches: 511.1592878
Found 272 metabolites which its exact mass value is equals to given mass value 511.1592878
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3-Methyl-1-hydroxybutyl-ThPP
3-Methyl-1-hydroxybutyl-ThPP is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15974). It is the second to last step in the synthesis of 3-methylbutanoyl-CoA and is converted from 4-methyl-2-oxopentanoate via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to S-(3-methylbutanoyl)-dihydrolipoamide-E via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. [HMDB] 3-Methyl-1-hydroxybutyl-ThPP is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15974). It is the second to last step in the synthesis of 3-methylbutanoyl-CoA and is converted from 4-methyl-2-oxopentanoate via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to S-(3-methylbutanoyl)-dihydrolipoamide-E via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4].
2-Methyl-1-hydroxybutyl-ThPP
2-Methyl-1-hydroxybutyl-ThPP is an intermediate in Valine, leucine and isoleucine degradation. 2-Methyl-1-hydroxybutyl-ThPP is the second to last step for the synthesis of (S)-2-Methylbutanoyl-CoA. 2-Methyl-1-hydroxybutyl-ThPP is converted from (S)-3-Methyl-2-oxopentanoic acid via the enzyme 2-oxoisovalerate dehydrogenase E1 component, alpha subunit(EC 1.2.4.4). It is then converted to S-(2-Methylbutanoyl)-dihydrolipoamide-E via the same enzyme. 2-Methyl-1-hydroxybutyl-ThPP is an intermediate in Valine, leucine and isoleucine degradation. 2-Methyl-1-hydroxybutyl-ThPP is the second to last step for the synthesis of (S)-2-Methylbutanoyl-CoA. 2-Methyl-1-hydroxybutyl-ThPP is converted
Hygromycin A
C23H29NO12 (511.16896740000004)
A natural product found in Streptomyces species.
Uzel (TN)
C20H21N7O7. Ca (511.11283060000005)
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative D018977 - Micronutrients > D014815 - Vitamins Therapeutic category: 3929 Levoleucovorin Calcium (Calcium levofolinate), a levo isoform of Leucovorin Calcium (HY-13664), possesses antineoplastic effects. Levoleucovorin Calcium is also an augmentor of 5-fluorouracil (HY-90006) cytotoxicity against cancer[1][2].
O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->3)-2-(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol
C20H33NO14 (511.19009580000005)
O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->3)-2-(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with a Mass-Spectrometry fragment spectral library (PMID: 16194087) [HMDB] O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->3)-2-(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with a Mass-Spectrometry fragment spectral library (PMID: 16194087).
O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->4)-2-(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol
C20H33NO14 (511.19009580000005)
O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->4)-2-(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087) [HMDB] O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->4)-2-(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol is a natural oligosaccharide of human milk identified with an Mass-Spectrometry fragment spectral library (PMID: 16194087).
Cefetamet pivoxyl
2-Biphenyl-4-yl-1-(1H-tetrazol-5-yl)ethylaminoethyl phosphonic acid
C28H26N5O3P (511.1773176000001)
Hygromycin A
C23H29NO12 (511.16896740000004)
Raticate
3-acetyl-3,12-dihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside
C27H29NO9 (511.18422240000007)
Cys Cys Met Arg
Cys Cys Arg Met
Cys Cys Thr Trp
Cys Cys Trp Thr
Cys Asp Phe Gln
C21H29N5O8S (511.17367540000004)
Cys Asp Gln Phe
C21H29N5O8S (511.17367540000004)
Cys Glu Phe Asn
C21H29N5O8S (511.17367540000004)
Cys Glu Asn Phe
C21H29N5O8S (511.17367540000004)
Cys Phe Asp Gln
C21H29N5O8S (511.17367540000004)
Cys Phe Glu Asn
C21H29N5O8S (511.17367540000004)
Cys Phe Gly Trp
C25H29N5O5S (511.18893040000006)
Cys Phe Asn Glu
C21H29N5O8S (511.17367540000004)
Cys Phe Gln Asp
C21H29N5O8S (511.17367540000004)
Cys Phe Trp Gly
C25H29N5O5S (511.18893040000006)
Cys Gly Phe Trp
C25H29N5O5S (511.18893040000006)
Cys Gly Trp Phe
C25H29N5O5S (511.18893040000006)
Cys Lys Met Met
C19H37N5O5S3 (511.19567120000005)
Cys Met Cys Arg
Cys Met Lys Met
C19H37N5O5S3 (511.19567120000005)
Cys Met Met Lys
C19H37N5O5S3 (511.19567120000005)
Cys Met Met Gln
Cys Met Gln Met
Cys Met Arg Cys
Cys Asn Glu Phe
C21H29N5O8S (511.17367540000004)
Cys Asn Phe Glu
C21H29N5O8S (511.17367540000004)
Cys Gln Asp Phe
C21H29N5O8S (511.17367540000004)
Cys Gln Phe Asp
C21H29N5O8S (511.17367540000004)
Cys Gln Met Met
Cys Arg Cys Met
Cys Arg Met Cys
Cys Thr Cys Trp
Cys Thr Trp Cys
Cys Trp Cys Thr
Cys Trp Phe Gly
C25H29N5O5S (511.18893040000006)
Cys Trp Gly Phe
C25H29N5O5S (511.18893040000006)
Cys Trp Thr Cys
Asp Cys Phe Gln
C21H29N5O8S (511.17367540000004)
Asp Cys Gln Phe
C21H29N5O8S (511.17367540000004)
Asp Phe Cys Gln
C21H29N5O8S (511.17367540000004)
Asp Phe Gln Cys
C21H29N5O8S (511.17367540000004)
Asp Asn Thr Tyr
C21H29N5O10 (511.19143340000005)
Asp Asn Tyr Thr
C21H29N5O10 (511.19143340000005)
Asp Gln Cys Phe
C21H29N5O8S (511.17367540000004)
Asp Gln Phe Cys
C21H29N5O8S (511.17367540000004)
Asp Gln Ser Tyr
C21H29N5O10 (511.19143340000005)
Asp Gln Tyr Ser
C21H29N5O10 (511.19143340000005)
Asp Ser Gln Tyr
C21H29N5O10 (511.19143340000005)
Asp Ser Tyr Gln
C21H29N5O10 (511.19143340000005)
Asp Thr Asn Tyr
C21H29N5O10 (511.19143340000005)
Asp Thr Tyr Asn
C21H29N5O10 (511.19143340000005)
Asp Tyr Asn Thr
C21H29N5O10 (511.19143340000005)
Asp Tyr Gln Ser
C21H29N5O10 (511.19143340000005)
Asp Tyr Ser Gln
C21H29N5O10 (511.19143340000005)
Asp Tyr Thr Asn
C21H29N5O10 (511.19143340000005)
Glu Cys Phe Asn
C21H29N5O8S (511.17367540000004)
Glu Cys Asn Phe
C21H29N5O8S (511.17367540000004)
Glu Phe Cys Asn
C21H29N5O8S (511.17367540000004)
Glu Phe Asn Cys
C21H29N5O8S (511.17367540000004)
Glu Asn Cys Phe
C21H29N5O8S (511.17367540000004)
Glu Asn Phe Cys
C21H29N5O8S (511.17367540000004)
Glu Asn Ser Tyr
C21H29N5O10 (511.19143340000005)
Glu Asn Tyr Ser
C21H29N5O10 (511.19143340000005)
Glu Ser Asn Tyr
C21H29N5O10 (511.19143340000005)
Glu Ser Tyr Asn
C21H29N5O10 (511.19143340000005)
Glu Tyr Asn Ser
C21H29N5O10 (511.19143340000005)
Glu Tyr Ser Asn
C21H29N5O10 (511.19143340000005)
Phe Cys Asp Gln
C21H29N5O8S (511.17367540000004)
Phe Cys Glu Asn
C21H29N5O8S (511.17367540000004)
Phe Cys Gly Trp
C25H29N5O5S (511.18893040000006)
Phe Cys Asn Glu
C21H29N5O8S (511.17367540000004)
Phe Cys Gln Asp
C21H29N5O8S (511.17367540000004)
Phe Cys Trp Gly
C25H29N5O5S (511.18893040000006)
Phe Asp Cys Gln
C21H29N5O8S (511.17367540000004)
Phe Asp Gln Cys
C21H29N5O8S (511.17367540000004)
Phe Glu Cys Asn
C21H29N5O8S (511.17367540000004)
Phe Glu Asn Cys
C21H29N5O8S (511.17367540000004)
Phe Gly Cys Trp
C25H29N5O5S (511.18893040000006)
Phe Gly Trp Cys
C25H29N5O5S (511.18893040000006)
Phe Asn Cys Glu
C21H29N5O8S (511.17367540000004)
Phe Asn Glu Cys
C21H29N5O8S (511.17367540000004)
Phe Gln Cys Asp
C21H29N5O8S (511.17367540000004)
Phe Gln Asp Cys
C21H29N5O8S (511.17367540000004)
Phe Trp Cys Gly
C25H29N5O5S (511.18893040000006)
Phe Trp Gly Cys
C25H29N5O5S (511.18893040000006)
Gly Cys Phe Trp
C25H29N5O5S (511.18893040000006)
Gly Cys Trp Phe
C25H29N5O5S (511.18893040000006)
Gly Phe Cys Trp
C25H29N5O5S (511.18893040000006)
Gly Phe Trp Cys
C25H29N5O5S (511.18893040000006)
Gly Ser Trp Tyr
Gly Ser Tyr Trp
Gly Trp Cys Phe
C25H29N5O5S (511.18893040000006)
Gly Trp Phe Cys
C25H29N5O5S (511.18893040000006)
Gly Trp Ser Tyr
Gly Trp Tyr Ser
Gly Tyr Ser Trp
Gly Tyr Trp Ser
Lys Cys Met Met
C19H37N5O5S3 (511.19567120000005)
Lys Met Cys Met
C19H37N5O5S3 (511.19567120000005)
Lys Met Met Cys
C19H37N5O5S3 (511.19567120000005)
Met Cys Cys Arg
Met Cys Lys Met
C19H37N5O5S3 (511.19567120000005)
Met Cys Met Lys
C19H37N5O5S3 (511.19567120000005)
Met Cys Met Gln
Met Cys Gln Met
Met Cys Arg Cys
Met Lys Cys Met
C19H37N5O5S3 (511.19567120000005)
Met Lys Met Cys
C19H37N5O5S3 (511.19567120000005)
Met Met Cys Lys
C19H37N5O5S3 (511.19567120000005)
Met Met Cys Gln
Met Met Lys Cys
C19H37N5O5S3 (511.19567120000005)
Met Met Gln Cys
Met Gln Cys Met
Met Gln Met Cys
Met Arg Cys Cys
Asn Cys Glu Phe
C21H29N5O8S (511.17367540000004)
Asn Cys Phe Glu
C21H29N5O8S (511.17367540000004)
Asn Asp Thr Tyr
C21H29N5O10 (511.19143340000005)
Asn Asp Tyr Thr
C21H29N5O10 (511.19143340000005)
Asn Glu Cys Phe
C21H29N5O8S (511.17367540000004)
Asn Glu Phe Cys
C21H29N5O8S (511.17367540000004)
Asn Glu Ser Tyr
C21H29N5O10 (511.19143340000005)
Asn Glu Tyr Ser
C21H29N5O10 (511.19143340000005)
Asn Phe Cys Glu
C21H29N5O8S (511.17367540000004)
Asn Phe Glu Cys
C21H29N5O8S (511.17367540000004)
Asn Ser Glu Tyr
C21H29N5O10 (511.19143340000005)
Asn Ser Tyr Glu
C21H29N5O10 (511.19143340000005)
Asn Thr Asp Tyr
C21H29N5O10 (511.19143340000005)
Asn Thr Tyr Asp
C21H29N5O10 (511.19143340000005)
Asn Tyr Asp Thr
C21H29N5O10 (511.19143340000005)
Asn Tyr Glu Ser
C21H29N5O10 (511.19143340000005)
Asn Tyr Ser Glu
C21H29N5O10 (511.19143340000005)
Asn Tyr Thr Asp
C21H29N5O10 (511.19143340000005)
Gln Cys Asp Phe
C21H29N5O8S (511.17367540000004)
Gln Cys Phe Asp
C21H29N5O8S (511.17367540000004)
Gln Cys Met Met
Gln Asp Cys Phe
C21H29N5O8S (511.17367540000004)
Gln Asp Phe Cys
C21H29N5O8S (511.17367540000004)
Gln Asp Ser Tyr
C21H29N5O10 (511.19143340000005)
Gln Asp Tyr Ser
C21H29N5O10 (511.19143340000005)
Gln Phe Cys Asp
C21H29N5O8S (511.17367540000004)
Gln Phe Asp Cys
C21H29N5O8S (511.17367540000004)
Gln Met Cys Met
Gln Met Met Cys
Gln Ser Asp Tyr
C21H29N5O10 (511.19143340000005)
Gln Ser Tyr Asp
C21H29N5O10 (511.19143340000005)
Gln Tyr Asp Ser
C21H29N5O10 (511.19143340000005)
Gln Tyr Ser Asp
C21H29N5O10 (511.19143340000005)
Arg Cys Cys Met
Arg Cys Met Cys
Arg Met Cys Cys
Ser Asp Gln Tyr
C21H29N5O10 (511.19143340000005)
Ser Asp Tyr Gln
C21H29N5O10 (511.19143340000005)
Ser Glu Asn Tyr
C21H29N5O10 (511.19143340000005)
Ser Glu Tyr Asn
C21H29N5O10 (511.19143340000005)
Ser Gly Trp Tyr
Ser Gly Tyr Trp
Ser Asn Glu Tyr
C21H29N5O10 (511.19143340000005)
Ser Asn Tyr Glu
C21H29N5O10 (511.19143340000005)
Ser Gln Asp Tyr
C21H29N5O10 (511.19143340000005)
Ser Gln Tyr Asp
C21H29N5O10 (511.19143340000005)
Ser Trp Gly Tyr
Ser Trp Tyr Gly
Ser Tyr Asp Gln
C21H29N5O10 (511.19143340000005)
Ser Tyr Glu Asn
C21H29N5O10 (511.19143340000005)
Ser Tyr Gly Trp
Ser Tyr Asn Glu
C21H29N5O10 (511.19143340000005)
Ser Tyr Gln Asp
C21H29N5O10 (511.19143340000005)
Ser Tyr Trp Gly
Thr Cys Cys Trp
Thr Cys Trp Cys
Thr Asp Asn Tyr
C21H29N5O10 (511.19143340000005)
Thr Asp Tyr Asn
C21H29N5O10 (511.19143340000005)
Thr Asn Asp Tyr
C21H29N5O10 (511.19143340000005)
Thr Asn Tyr Asp
C21H29N5O10 (511.19143340000005)
Thr Trp Cys Cys
Thr Tyr Asp Asn
C21H29N5O10 (511.19143340000005)
Thr Tyr Asn Asp
C21H29N5O10 (511.19143340000005)
Trp Cys Cys Thr
Trp Cys Phe Gly
C25H29N5O5S (511.18893040000006)
Trp Cys Gly Phe
C25H29N5O5S (511.18893040000006)
Trp Cys Thr Cys
Trp Phe Cys Gly
C25H29N5O5S (511.18893040000006)
Trp Phe Gly Cys
C25H29N5O5S (511.18893040000006)
Trp Gly Cys Phe
C25H29N5O5S (511.18893040000006)
Trp Gly Phe Cys
C25H29N5O5S (511.18893040000006)
Trp Gly Ser Tyr
Trp Gly Tyr Ser
Trp Ser Gly Tyr
Trp Ser Tyr Gly
Trp Thr Cys Cys
Trp Tyr Gly Ser
Trp Tyr Ser Gly
Tyr Asp Asn Thr
C21H29N5O10 (511.19143340000005)
Tyr Asp Gln Ser
C21H29N5O10 (511.19143340000005)
Tyr Asp Ser Gln
C21H29N5O10 (511.19143340000005)
Tyr Asp Thr Asn
C21H29N5O10 (511.19143340000005)
Tyr Glu Asn Ser
C21H29N5O10 (511.19143340000005)
Tyr Glu Ser Asn
C21H29N5O10 (511.19143340000005)
Tyr Gly Ser Trp
Tyr Gly Trp Ser
Tyr Asn Asp Thr
C21H29N5O10 (511.19143340000005)
Tyr Asn Glu Ser
C21H29N5O10 (511.19143340000005)
Tyr Asn Ser Glu
C21H29N5O10 (511.19143340000005)
Tyr Asn Thr Asp
C21H29N5O10 (511.19143340000005)
Tyr Gln Asp Ser
C21H29N5O10 (511.19143340000005)
Tyr Gln Ser Asp
C21H29N5O10 (511.19143340000005)
Tyr Ser Asp Gln
C21H29N5O10 (511.19143340000005)
Tyr Ser Glu Asn
C21H29N5O10 (511.19143340000005)
Tyr Ser Gly Trp
Tyr Ser Asn Glu
C21H29N5O10 (511.19143340000005)
Tyr Ser Gln Asp
C21H29N5O10 (511.19143340000005)
Tyr Ser Trp Gly
Tyr Thr Asp Asn
C21H29N5O10 (511.19143340000005)
Tyr Thr Asn Asp
C21H29N5O10 (511.19143340000005)
Tyr Trp Gly Ser
Tyr Trp Ser Gly
O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->3)-2-(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol
C20H33NO14 (511.19009580000005)
O-6-deoxy-a-L-galactopyranosyl-(1->2)-O-b-D-galactopyranosyl-(1->4)-2-(acetylamino)-1,5-anhydro-2-deoxy-D-arabino-Hex-1-enitol
C20H33NO14 (511.19009580000005)
sodium 3-[[4-(benzoylethylamino)-2-methylphenyl]azo]-4-hydroxynaphthalene-1-sulphonate
C26H22N3NaO5S (511.1177802000001)
Arzoxifene hydrochloride
C28H30ClNO4S (511.1583970000001)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
Leucovorin Calcium
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative D018977 - Micronutrients > D014815 - Vitamins Levoleucovorin Calcium (Calcium levofolinate), a levo isoform of Leucovorin Calcium (HY-13664), possesses antineoplastic effects. Levoleucovorin Calcium is also an augmentor of 5-fluorouracil (HY-90006) cytotoxicity against cancer[1][2].
2,6-bis(bis(4-fluorophenyl)methyl)-4-methylaniline
Cefetamet Pivoxil
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
(2-Amino-2-biphenylyl)(chloro)palladium - tris(2-methyl-2-propanyl)phosphine (1:1)
C24H37ClNPPd (511.1386752000001)
(E)-CefetametPivoxil
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
7,10,13-Tri(carboxymethyl)-5,15-dioxo-4,7,10,13,16-pentaaza-1,19-dithianonadecane
(E)-N-[(3aS,4R,5S,6S,7R,7aR)-4,6,7-trihydroxy-3a,4,5,6,7,7a-hexahydro-1,3-benzodioxol-5-yl]-3-[4-[(2S,3S,4S,5S)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy-3-hydroxyphenyl]-2-methylprop-2-enamide
C23H29NO12 (511.16896740000004)
(E)-3-[4-(5-acetyl-3,4-dihydroxyoxolan-2-yl)oxy-3-hydroxyphenyl]-2-methyl-N-(4,6,7-trihydroxy-3a,4,5,6,7,7a-hexahydro-1,3-benzodioxol-5-yl)prop-2-enamide
C23H29NO12 (511.16896740000004)
2-[(3-cyano-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-2-yl)thio]-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]acetamide
alpha-Kdo1Me-(2->8)-alpha-Kdo-OAll(1-)
C20H31O15- (511.16628760000003)
O-[N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-alpha-D-galactosaminyl]-L-serine
C19H33N3O13 (511.20132880000006)
CGP71683 hydrochloride
C26H30ClN5O2S (511.18086300000004)
CGP71683 hydrochloride is a competitive neuropeptide Y5 receptor antagonist with a Ki of 1.3 nM, and shows no obvious activity at Y1 receptor (Ki, >4000 nM) and Y2 receptor (Ki, 200 nM) in cell membranes.
CVT-11127
CVT-11127 is a potent SCD inhibitor. CVT-11127 induces apoposis and arrests the cell cycle at the G1/S phase. CVT-11127 has the potential for the research of lung cancer[1]. CVT-11127 is a potent SCD inhibitor. CVT-11127 induces apoposis and arrests the cell cycle at the G1/S phase. CVT-11127 has the potential for the research of lung cancer[1].
PPTN (hydrochloride)
PPTN hydrochloride is a potent, high-affinity, competitive and highly selective P2Y14 receptor antagonist with a KB value of 434 pM. PPTN hydrochloride exhibits no agonist or antagonist effect at the P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, or P2Y13 receptors. Anti-inflammatory and anti-immune activity[1].
(2e)-n-[(3ar,4s,5s,6r,7s,7as)-4,6,7-trihydroxy-hexahydro-2h-1,3-benzodioxol-5-yl]-3-(4-{[(2s,3s,4s,5s)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methylprop-2-enimidic acid
C23H29NO12 (511.16896740000004)
(1s,11s,13s,14r,15s,16s)-15-hydroxy-14-methoxy-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-yl 3,4-dimethoxybenzoate
C27H29NO9 (511.18422240000007)
(5s,7r,8s,9r,10r,18r)-18-ethyl-9,10-dihydroxy-8-methoxy-7,23-dimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15,20-tetrone
(1r,2s,10r,12r,13r,16s,19s)-16,19-dihydroxy-10-(hydroxymethyl)-7,18-dimethoxy-6,17,21-trimethyl-5,8,14-trioxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15(20),17-tetraene-12-carbonitrile
(2e)-3-(4-{[(2s,3s,4s,5s)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methyl-n-[(4r,5r,6s,7r)-4,6,7-trihydroxy-hexahydro-2h-1,3-benzodioxol-5-yl]prop-2-enimidic acid
C23H29NO12 (511.16896740000004)
1-[5-({[2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}(carboxy)methyl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyimidazole-4-carboxylic acid
C20H25N5O11 (511.15504999999996)